← Leaderboards
Anna N. A. Tosteson
Dartmouth College
$20,584,945
Attributed
$32,439,273
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$72,577,665 · 19
AHRQ$3,714,849 · 3
By mechanism
P01$34,625,817 · 5
U54$9,410,276 · 4
UM1$8,141,832 · 1
P60$6,315,468 · 2
R01$6,192,290 · 3
U01$4,229,675 · 1
Top collaborators
- Karla M Kerlikowske14 shared
- Diana L Miglioretti14 shared
- Jennifer S Haas11 shared
- Tracy Onega6 shared
- Steven J Atlas5 shared
- Sandra L Wong3 shared
- Steven L. Bernstein2 shared
- William C Black2 shared
Most similar at Dartmouth College
Same institution · by research overlap
- James N Weinstein$22,565,241
- Keith D. Paulsen$38,192,657
- Nancy J Birkmeyer$3,148,018
- Jon D Lurie$9,254,423
- Jonathan L Skinner$2,376,906
Others in their field
Top investigators on “Breast Cancer Detection”
- Peter J O'Dwyer · University Of Pennsylvania$40,975,037
- Mitchell D Schnall · University Of Pennsylvania$40,712,729
- Lynne I. Wagner · Northwestern University At Chicago$38,937,603
- Diana L Miglioretti · Group Health Cooperative$33,013,957
- Barbara Wallace · Nysdoh/Health Research, Inc.$32,724,508
- Craig B Thompson · Sloan-Kettering Inst Can Research$27,714,083
Research focus
Breast Cancer DetectionScreeningBaseProgramsWomanComparative EffectivenessCaringBreastMalignant Breast NeoplasmResourcesServicesInnovationMortalityEffectivenessBiometryImageCollaborationsScienceSiteMultidisciplinaryMalignant NeoplasmsResearch PersonnelBreast Cancer Surveillance ConsortiumPerformance
Grant awards (84)
Dartmouth Clinical and Translational Science Institute$4,068,641
UM1 · FY2025 · TR
Advancing Risk-based Breast Cancer Screening and Surveillance in Community Practice$2,561,132
P01 · FY2025 · CA
Dartmouth Learning Health System (LHS) Embedded Scientist Training and Research (E-STaR) Center$999,574
P30 · FY2025 · HS · contact PI
Comparative Effectiveness Core$426,854
P01 · FY2025 · CA · contact PI
Administrative Core$260,355
P30 · FY2025 · HS · contact PI
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice$43,085
P01 · FY2025 · CA
Comparative Effectiveness Core$43,085
P01 · FY2025 · CA · contact PI
Dartmouth Clinical and Translational Science Institute$4,073,191
UM1 · FY2024 · TR
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice$2,478,012
P01 · FY2024 · CA
Dartmouth Learning Health System (LHS) Embedded Scientist Training and Research (E-STaR) Center$999,750
P30 · FY2024 · HS · contact PI
Administrative Core$355,689
P30 · FY2024 · HS · contact PI
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice$209,440
P01 · FY2024 · CA
Community Outreach and Engagement$198,486
P30 · FY2024 · CA · contact PI
Refining and expanding breast dosimetry for the Sacramento Area Breast Imaging Registry$117,898
P01 · FY2024 · CA
Comparative Effectiveness Core$104,590
P01 · FY2024 · CA · contact PI
Community Outreach and Engagement$5,263
P30 · FY2024 · CA · contact PI
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice$2,928,797
P01 · FY2023 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients$627,289
R01 · FY2023 · CA · contact PI
Comparative Effectiveness Core$199,277
P01 · FY2023 · CA · contact PI
Community Outreach and Engagement$198,488
P30 · FY2023 · CA · contact PI
Advancing Equitable Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,818,184
P01 · FY2022 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients$647,401
R01 · FY2022 · CA · contact PI
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention$419,366
U01 · FY2022 · CA
Comparative Effectiveness Core$212,705
P01 · FY2022 · CA · contact PI
Community Outreach and Engagement$198,488
P30 · FY2022 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,379,703
P01 · FY2021 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention$885,645
U01 · FY2021 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients$655,190
R01 · FY2021 · CA · contact PI
Comparative Effectiveness Core$384,117
P01 · FY2021 · CA · contact PI
Community Outreach and Engagement$198,488
P30 · FY2021 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,548,448
P01 · FY2020 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention$982,509
U01 · FY2020 · CA
Comparative Effectiveness Core$470,920
P01 · FY2020 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice - Admin Supplement for P3$149,977
P01 · FY2020 · CA
Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,238,201
P01 · FY2019 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention$965,430
U01 · FY2019 · CA
Comparative Effectiveness Core$316,534
P01 · FY2019 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,475,469
P01 · FY2018 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention$976,725
U01 · FY2018 · CA
Comparative Effectiveness Core$405,560
P01 · FY2018 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice$200,000
P01 · FY2018 · CA
Comparative Effectiveness Core$33,334
P01 · FY2018 · CA · contact PI
Risk-based Breast Cancer Screening and Surveillance in Community Practice$3,500,336
P01 · FY2017 · CA
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$660,918
U54 · FY2017 · CA · contact PI
Comparative Effectiveness Core$246,861
P01 · FY2017 · CA · contact PI
NIAMS Multidisciplinary Clinical Research Center$1,201,400
P60 · FY2016 · AR · contact PI
NIAMS Multidisciplinary Clinical Research Center$1,202,521
P60 · FY2015 · AR · contact PI
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$1,113,298
U54 · FY2015 · CA · contact PI
BIOSTATISTICS$649,675
U54 · FY2015 · CA · contact PI
Comparative Effectiveness Core$557,352
P01 · FY2015 · CA · contact PI
CORES$113,651
U54 · FY2015 · CA · contact PI
Comparative Effectiveness of Care Systems 8 Established 8 Emerging Modalities$43,203
U54 · FY2015 · CA · contact PI
NIAMS Multidisciplinary Clinical Research Center$1,251,280
P60 · FY2014 · AR · contact PI
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$1,109,727
U54 · FY2014 · CA · contact PI
BIOSTATISTICS$636,417
U54 · FY2014 · CA · contact PI
Comparative Effectiveness Core$560,345
P01 · FY2014 · CA · contact PI
CORES$109,563
U54 · FY2014 · CA · contact PI
Comparative Effectiveness of Care Systems 8 Established 8 Emerging Modalities$41,925
U54 · FY2014 · CA · contact PI
NIAMS Multidisciplinary Clinical Research Center$1,194,805
P60 · FY2013 · AR · contact PI
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$1,098,977
U54 · FY2013 · CA · contact PI
BIOSTATISTICS$771,783
U54 · FY2013 · CA · contact PI
Comparative Effectiveness Core$510,890
P01 · FY2013 · CA · contact PI
CORES$207,169
U54 · FY2013 · CA · contact PI
Comparative Effectiveness of Care Systems 8 Established 8 Emerging Modalities$131,362
U54 · FY2013 · CA · contact PI
NIAMS Multidisciplinary Clinical Research Center$1,276,531
P60 · FY2012 · AR · contact PI
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$851,562
U54 · FY2012 · CA · contact PI
BIOSTATISTICS$519,642
U54 · FY2012 · CA · contact PI
Comparative Effectiveness Core$504,711
P01 · FY2012 · CA · contact PI
CORES$80,532
U54 · FY2012 · CA · contact PI
Comparative Effectiveness of Care Systems 8 Established 8 Emerging Modalities$26,656
U54 · FY2012 · CA · contact PI
Advancing Systems Approaches to Personal and Population Breast Cancer Screening$1,244,216
U54 · FY2011 · CA · contact PI
Comparative Effectiveness of Treatments for Degenerative Spine Disease$361,691
R01 · FY2011 · HS · contact PI
Comparative Effectiveness of Advanced Imaging in Cancer$1,963,302
UC2 · FY2010 · CA · contact PI
Comparative Effectiveness of Treatments for Degenerative Spine Disease$378,128
R01 · FY2010 · HS · contact PI
Comparative Effectiveness of Advanced Imaging in Cancer$1,999,273
RC2 · FY2009 · CA · contact PI
Comparative Effectiveness of Treatments for Degenerative Spine Disease$359,662
R01 · FY2009 · HS · contact PI
Prognostic Value of Lumbar Spine MRI$188,931
P60 · FY2007 · AR · contact PI
Evaluation of Osteoporosis Prevention in the Elderly$373,051
R01 · FY2006 · AG · contact PI
Evaluation of Osteoporosis Prevention in the Elderly$374,154
R01 · FY2005 · AG
Evaluation of Osteoporosis Prevention in the Elderly$434,884
R01 · FY2004 · AG
Evaluation of Osteoporosis Prevention in the Elderly$637,728
R01 · FY2003 · AG
Evaluation of Osteoporosis Prevention in the Elderly$610,658
R01 · FY2002 · AG
EVALUATION OF OSTEOPOROSIS PREVENTION IN THE ELDERLY$242,365
R01 · FY2001 · AG
EVALUATION OF OSTEOPOROSIS PREVENTION IN THE ELDERLY$490,089
R01 · FY2000 · AG